Article Details

Neurocrine Biosciences (NASDAQ:NBIX) Stock Rating Upgraded by Zacks Investment Research

Retrieved on: 2021-04-14 07:18:45

Tags for this article:

Click the tags to see associated articles and topics

Neurocrine Biosciences (NASDAQ:NBIX) Stock Rating Upgraded by Zacks Investment Research. View article details on hiswai:

Excerpt

AQR Capital Management LLC now owns 49,124 shares of the company's stock valued at $4,724,000 after acquiring an additional 957 shares during ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up